Mass Tort Advertising Campaign

1,4-Dioxane Contamination Marketing & Claimant Acquisition

1,4-Dioxane litigation targets the industrial solvent stabilizer and manufacturing byproduct that has seeped into groundwater and public water supplies across the country — a chemical federal regulators classify as a likely human carcinogen that conventional water treatment does not remove. Residents of affected communities allege their cancers trace to years of drinking contaminated water, and water districts are suing the manufacturers for the treatment costs.

For plaintiff firms, 1,4-dioxane sits where PFAS was several years ago: contamination mapping expanding, municipal litigation building the liability record, and personal injury filings following behind it.

1,4-Dioxane Contamination at a glance

Manufacturer(s)
Chemical Manufacturers (various)
Associated injuries
Cancer from Contaminated Water
Litigation status
DEVELOPING
Campaign intake
Open

The litigation landscape

The litigation runs on two tracks. Water providers — most prominently on Long Island, where contamination is concentrated — have pursued manufacturers for the cost of removing the chemical, and those cases have built the documentary record on sources and knowledge. Personal injury claims by residents with kidney and liver cancers and related diagnoses build on that foundation, community by community.

Because 1,4-dioxane co-occurs with other contaminants at many sites, screening and expert strategy borrow heavily from the PFAS playbook: exposure duration through address history, water district records, and diagnosis mapping.

Who a campaign targets

Screening criteria in 1,4-dioxane matters typically include:

  • Sustained residence in a community with documented 1,4-dioxane contamination in its water supply
  • A diagnosis in the associated profile — kidney and liver cancers most prominently
  • Exposure duration supportable through address and water-service history
  • Claims within the state's limitations rules, with discovery accrual tied to public disclosure of the contamination

How MTAA runs 1,4-Dioxane Contamination campaigns

Like all water contamination torts, this is community-targeted advertising: campaigns run against the specific water districts and towns where testing has documented contamination, and creative that names the community outperforms generic messaging by a wide margin. Every new testing disclosure and municipal filing creates a local awareness spike.

MTAA runs contamination campaigns with district-level targeting and address-history screening — the model proven across our PFAS and water torts.

Pricing

Mass Tort Ad Agency runs 1,4-Dioxane Contamination campaigns on the same transparent model as every tort: actual Meta ad spend at cost plus a flat 15% management fee, a one-time $1,000 setup fee per tort, and $100 per signed retainer for CloudIntake qualification. No per-case markups, no lead resale, and the firm owns its ad account, pixel, creative, and claimant data.

1,4-Dioxane Contamination advertising — common questions

How does 1,4-dioxane compare to PFAS litigation?
It is earlier on the same curve: municipal cost-recovery suits are building the liability record while personal injury filings grow behind them. Firms that entered PFAS early recognize the stage.
Where is contamination concentrated?
Long Island is the most litigated region, but documented contamination spans water systems in many states — and each new testing disclosure adds targetable communities.
What proves exposure?
Address and water-service history against the district's contamination record. The chemical resists standard treatment, so documented presence in the supply implies exposure for the service population.
Is this tort ready to advertise?
In documented communities, yes — district-targeted campaigns reach a defined exposed population efficiently, and early positioning matters in developing water torts. Ask for current contamination campaign benchmarks.

Ready to run 1,4-Dioxane Contamination campaigns?

We build, run, and qualify 1,4-Dioxane Contamination claimant-acquisition campaigns end to end. Book a call and we'll walk you through the creative, audience, and intake plan.

Book a strategy call